172 related articles for article (PubMed ID: 31501152)
1. Serologic Profile of Antiparietal Cell Antibodies, Pepsinogens, and
Wang SM; Roth MJ; Murphy GA; Dawsey SM; Fan JH; Taylor PR; Qiao YL; Abnet CC
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2022-2029. PubMed ID: 31501152
[TBL] [Abstract][Full Text] [Related]
2. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany.
Zhang Y; Weck MN; Schöttker B; Rothenbacher D; Brenner H
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):821-6. PubMed ID: 23456556
[TBL] [Abstract][Full Text] [Related]
3. Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.
Cook MB; Dawsey SM; Diaw L; Blaser MJ; Perez-Perez GI; Abnet CC; Taylor PR; Albanes D; Virtamo J; Kamangar F
Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1966-75. PubMed ID: 20647397
[TBL] [Abstract][Full Text] [Related]
4. Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer.
Song M; Camargo MC; Katki HA; Weinstein SJ; Männistö S; Albanes D; Surcel HM; Rabkin CS
JAMA Oncol; 2022 Feb; 8(2):268-274. PubMed ID: 34913949
[TBL] [Abstract][Full Text] [Related]
5. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
6. Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.
Abnet CC; Zheng W; Ye W; Kamangar F; Ji BT; Persson C; Yang G; Li HL; Rothman N; Shu XO; Gao YT; Chow WH
Br J Cancer; 2011 Apr; 104(9):1511-6. PubMed ID: 21407214
[TBL] [Abstract][Full Text] [Related]
7. Serum thyroglobulin, a biomarker for iodine deficiency, is not associated with increased risk of upper gastrointestinal cancers in a large Chinese cohort.
Lin SW; Fan JH; Dawsey SM; Taylor PR; Qiao YL; Abnet CC
Int J Cancer; 2011 Nov; 129(9):2284-9. PubMed ID: 21105043
[TBL] [Abstract][Full Text] [Related]
8. Serum ghrelin and esophageal and gastric cancer in two cohorts in China.
Pritchett NR; Maziarz M; Shu XO; Kamangar F; Dawsey SM; Fan JH; Ji BT; Gao YT; Xiang YB; Qiao YL; Li H; Yang G; Wang SM; Stanczyk FZ; Chow WH; Katki HA; Zheng W; Lan Q; Freedman ND; Rothman N; Abnet CC; Murphy G
Int J Cancer; 2020 May; 146(10):2728-2735. PubMed ID: 31351006
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma.
Parsonnet J; Samloff IM; Nelson LM; Orentreich N; Vogelman JH; Friedman GD
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):461-6. PubMed ID: 8220091
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China.
Kamangar F; Qiao YL; Schiller JT; Dawsey SM; Fears T; Sun XD; Abnet CC; Zhao P; Taylor PR; Mark SD
Int J Cancer; 2006 Aug; 119(3):579-84. PubMed ID: 16496409
[TBL] [Abstract][Full Text] [Related]
13. Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China.
Gao P; Cai N; Yang X; Yuan Z; Zhang T; Lu M; Jin L; Ye W; Suo C; Chen X
Int J Cancer; 2022 Jan; 150(2):243-252. PubMed ID: 34498732
[TBL] [Abstract][Full Text] [Related]
14. Serum pepsinogens and Helicobacter pylori are not associated with esophageal squamous cell carcinoma in a high-risk area in China.
Xue L; Xing L; Wang J; Shen H; Cui J; Mi J; Wang J; Misumi J; Zhang X
Tumori; 2013; 99(2):134-8. PubMed ID: 23748803
[TBL] [Abstract][Full Text] [Related]
15. Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.
Shakeri R; Malekzadeh R; Nasrollahzadeh D; Pawlita M; Murphy G; Islami F; Sotoudeh M; Michel A; Etemadi A; Waterboer T; Poustchi H; Brennan P; Boffetta P; Dawsey SM; Kamangar F; Abnet CC
Cancer Res; 2015 Nov; 75(22):4876-83. PubMed ID: 26383162
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
[TBL] [Abstract][Full Text] [Related]
18. Severity of atrophic gastritis related to antiparietal cell antibody and gastric carcinogenesis, including p53 mutations.
Taguchi A; Ohmiya N; Itoh A; Hirooka Y; Niwa Y; Mori N; Goto H
J Gastroenterol Hepatol; 2006 Mar; 21(3):545-51. PubMed ID: 16638096
[TBL] [Abstract][Full Text] [Related]
19. Changing trends in cancer incidence of upper aerodigestive tract and stomach in Japanese alcohol-dependent men (1993-2018).
Yokoyama A; Omori T; Yokoyama T
Cancer Med; 2020 Jan; 9(2):837-846. PubMed ID: 31957322
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection and fundic gastric atrophy are not associated with esophageal squamous cell carcinoma: a case-control study.
Venerito M; Kohrs S; Wex T; Adolf D; Kuester D; Schubert D; Peitz U; Mönkemüller K; Malfertheiner P
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):859-64. PubMed ID: 21811162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
